Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesenteric venous thrombosis attributed to docetaxel.

J Feenstra1, R J Vermeer, B H Stricker

  • 1Drug Safety Unit, Inspectorate for Health Care, The Hague, The Netherlands. feenstra@epib.fgg.eur.nl

American Journal of Clinical Oncology
|August 24, 2000
PubMed
Summary

A patient with metastatic breast cancer developed mesenteric venous thrombosis after docetaxel treatment. This rare adverse event highlights the need to assess docetaxel

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone microarchitecture and strength assessment in adults with osteogenesis imperfecta using HR-pQCT: normative comparison and challenges.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2024
Same author

Are higher antidepressant plasma concentrations associated with fall risk in older antidepressant users?

European geriatric medicine·2023
Same author

Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.

PloS one·2022
Same author

Candidate genetic variants and antidepressant-related fall risk in middle-aged and older adults.

PloS one·2022
Same author

Appendectomy and the subsequent risk of cancer: A prospective population-based cohort study with long follow-up.

Cancer epidemiology·2022
Same author

A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons.

Drugs & aging·2021

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Metastatic breast cancer requires effective treatment options.
  • Docetaxel is a chemotherapy agent used for various cancers.

Observation:

  • A 57-year-old woman with advanced breast cancer received docetaxel.
  • She experienced progressive pulmonary and sternal metastases.

Findings:

  • The patient developed mesenteric venous thrombosis within one week of the first docetaxel dose.
  • This suggests a potential rare adverse reaction to docetaxel.

Implications:

  • Careful monitoring for rare adverse events like venous thrombosis is crucial during docetaxel therapy.
  • Further clinical trials are needed to establish the risk-benefit profile of docetaxel.

Related Experiment Videos